EsoCheck collects cells from the lower esophagus without the need for an endoscopy. Patients swallow the pill-sized device that inflates and swabs for cells.
Florida Digestive Health Specialists is the first practice in the state to perform the test.
“This technology gives us an opportunity to find many of the 94-95 percent of patients who are at risk for developing esophageal cancer but don’t know it,” Scott Corbett, MD, director of the Barrett’s Esophagus Institute at Florida Digestive Health Specialists said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.